M&A in the Vet Space Continues

While animal health is not at the top of the news cycle in healthcare, it continues to be a space that attracts considerable PE attention and money. On the one hand there is the fact that “translational medicine” has increasingly become mainstream in the last decade and the dollars being spent on animal health continue to rise.

Case in point – the Australian Financial Review reported this week that PE giant Ares has entered the bidding for VetPartners out of Europe. It is expected that this deal will climb well North of $1B.

While there were off the radar deals in the vet space at one point, the cats out of the bag and so is the money.


Recent Posts

Tax Strategies – QSBS

There are three things that create drag on investment returns: 1) Losses 2) Taxes 3)…

Financings – Cont. from Vital Signs 12/1/23

We had several financings that didnt make the 12/1 edition of Vital Signs. Biolexis Therapeutics…


When a startup or an investment is successful, it’s more likely that we attribute the…